Cargando…
Hypoglycemia associated with off-label sitagliptin use
PURPOSE: To describe a case of hypoglycemia induced by off-label use of sitagliptin in an adult patient with type 2 diabetes. CASE SUMMARY: Addition of sitagliptin to metformin, glimepiride, and NovoLog(®) 70/30 Mix induced hypoglycemia in a 55-year-old Caucasian female. Hypoglycemia improved, altho...
Autores principales: | Whitley, Heather P, Kelley, Kristi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643046/ https://www.ncbi.nlm.nih.gov/pubmed/23745054 |
Ejemplares similares
-
Multiple drugs: Various toxicities, off-label use and no response to off-label therapy: case report
Publicado: (2021) -
Fixed drug eruption to sitagliptin
por: Gupta, Mrinal, et al.
Publicado: (2015) -
Linezolid-Associated Hypoglycemia
por: Johannesmeyer, Herman Joseph, et al.
Publicado: (2017) -
Antineoplastics: Pancytopenia and off-label use: case report
Publicado: (2020) -
Nafamostat: Off-label use and hyperkalaemia: case report
Publicado: (2020)